• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维素衍生物作为有效的利托那韦三元固体分散体再结晶抑制剂:体内外评价。

Cellulose derivatives as effective recrystallization inhibitor for ternary ritonavir solid dispersions: In vitro-in vivo evaluation.

机构信息

Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China.

Institute of Biopharmaceutical Research, Liaocheng University, Hunan Road, Liaocheng, Shandong 252059, People's Republic of China.

出版信息

Carbohydr Polym. 2021 Dec 1;273:118562. doi: 10.1016/j.carbpol.2021.118562. Epub 2021 Aug 18.

DOI:10.1016/j.carbpol.2021.118562
PMID:34560973
Abstract

Amorphous solid dispersions (ASDs) are regarded as one of the most promising techniques for poorly-soluble active pharmaceutical ingredients (API). However, the thermodynamic instability of ASDs at supersaturated state makes them easy to recrystallize in aqueous media. In this study, ritonavir (RTV) was selected as a model drug for evaluating the solubility enhancement and recrystallization inhibition effect of various cellulose derivatives and the combinations of them with typical surfactants. Combination of HPMCAS-HF/SLS was filtrated for preparing ternary RTV solid dispersions (RTV SD) via solvent evaporation method. RTV SD exhibited enhanced dissolution manner, while the oral bioavailability of RTV SD was equivalent with the Reference Standard Norvir® but increased significantly compared to the ternary physical mixture. Thus, the ternary SD system might be promisingly employed as efficient drug delivery system for RTV, while the HPMCAS-HF/SLS combination could be recommended as effective excipient for fabricating steady solid dispersions loading poorly soluble API.

摘要

无定形固体分散体(ASD)被认为是提高难溶性活性药物成分(API)溶解度的最有前途的技术之一。然而,ASD 在过饱和状态下的热力学不稳定性使得它们在水介质中容易重结晶。在这项研究中,利托那韦(RTV)被选为模型药物,用于评估各种纤维素衍生物及其与典型表面活性剂组合的增溶和抑制重结晶效果。通过溶剂蒸发法,将 HPMCAS-HF/SLS 的组合过滤用于制备三元 RTV 固体分散体(RTV SD)。RTV SD 表现出增强的溶解方式,而 RTV SD 的口服生物利用度与参比标准 Norvir®相当,但与三元物理混合物相比显著增加。因此,三元 SD 系统有望作为 RTV 的有效药物传递系统,而 HPMCAS-HF/SLS 组合可作为制备负载难溶性 API 的稳定固体分散体的有效赋形剂。

相似文献

1
Cellulose derivatives as effective recrystallization inhibitor for ternary ritonavir solid dispersions: In vitro-in vivo evaluation.纤维素衍生物作为有效的利托那韦三元固体分散体再结晶抑制剂:体内外评价。
Carbohydr Polym. 2021 Dec 1;273:118562. doi: 10.1016/j.carbpol.2021.118562. Epub 2021 Aug 18.
2
Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.利托那韦无定形固体分散体在水合和溶解过程中的相行为。
Pharm Res. 2017 Dec;34(12):2842-2861. doi: 10.1007/s11095-017-2265-5. Epub 2017 Sep 27.
3
Solid self-microemulsifying drug delivery system of ritonavir.利托那韦固体自微乳药物传递系统。
Drug Dev Ind Pharm. 2014 Apr;40(4):477-87. doi: 10.3109/03639045.2013.768632. Epub 2013 Mar 7.
4
Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.通过冻干乳基固体分散体提高难溶性药物利托那韦的水溶性和渗透性。
Pharm Dev Technol. 2017 Feb;22(1):90-102. doi: 10.1080/10837450.2016.1193193. Epub 2016 Jun 13.
5
Effect of plasticizers on manufacturing ritonavir/copovidone solid dispersions via hot-melt extrusion: Preformulation, physicochemical characterization, and pharmacokinetics in rats.增塑剂对热熔挤出制备利托那韦/共聚维酮固体分散体的影响:制剂前研究、理化性质表征和在大鼠体内的药代动力学。
Eur J Pharm Sci. 2019 Jan 15;127:60-70. doi: 10.1016/j.ejps.2018.10.020. Epub 2018 Oct 19.
6
Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.喷雾干燥三元无定形固体分散体的固态特性和溶出特性研究:多组分无定形系统设计和开发的合理步骤。
Mol Pharm. 2018 Sep 4;15(9):3796-3812. doi: 10.1021/acs.molpharmaceut.8b00306. Epub 2018 Jul 30.
7
Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.表面活性剂对利托那韦无定形固体分散体和共聚维酮释放性能的作用。
Pharm Res. 2022 Feb;39(2):381-397. doi: 10.1007/s11095-022-03183-4. Epub 2022 Feb 15.
8
Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.表面活性剂含无定形固体分散体的药物释放:表面活性剂在释放增强中的机制和作用。
Pharm Res. 2023 Dec;40(12):2817-2845. doi: 10.1007/s11095-023-03502-3. Epub 2023 Apr 13.
9
Encapsulation of astaxanthin in OSA-starch based amorphous solid dispersions with HPMCAS-HF/Soluplus® as effective recrystallization inhibitor.以 HPMCAS-HF/Soluplus®为有效抗结晶抑制剂的 OSA-淀粉无定形固体分散体包封虾青素。
Int J Biol Macromol. 2024 Nov;279(Pt 1):135421. doi: 10.1016/j.ijbiomac.2024.135421. Epub 2024 Sep 30.
10
Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.利托那韦与槲皮素稳定二元非晶相的制备、固态表征及生物利用度评估
Eur J Pharm Biopharm. 2015 Jan;89:329-38. doi: 10.1016/j.ejpb.2014.12.025. Epub 2014 Dec 24.

引用本文的文献

1
The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability.含奈玛特韦和利托那韦口服溶液的研发及其药代动力学和稳定性评估。
Pharmaceutics. 2024 Jan 14;16(1):109. doi: 10.3390/pharmaceutics16010109.
2
Effect of Span 20 Feeding Zone in the Twin Screw Extruder on the Properties of Amorphous Solid Dispersion of Ritonavir.双螺杆挤出机中Span 20喂料区对利托那韦无定形固体分散体性质的影响。
Pharmaceutics. 2023 Jan 29;15(2):441. doi: 10.3390/pharmaceutics15020441.
3
Enteric Polymer-Based Amorphous Solid Dispersions Enhance Oral Absorption of the Weakly Basic Drug Nintedanib via Stabilization of Supersaturation.
基于肠溶聚合物的无定形固体分散体通过超饱和稳定化增强弱碱性药物尼达尼布的口服吸收。
Pharmaceutics. 2022 Aug 30;14(9):1830. doi: 10.3390/pharmaceutics14091830.